Computational Analysis of the Inhibition Mechanism of NOTUM by the ONIOM Method.


Journal

ACS omega
ISSN: 2470-1343
Titre abrégé: ACS Omega
Pays: United States
ID NLM: 101691658

Informations de publication

Date de publication:
19 Apr 2022
Historique:
received: 21 02 2022
accepted: 28 03 2022
entrez: 27 4 2022
pubmed: 28 4 2022
medline: 28 4 2022
Statut: epublish

Résumé

Notum is a member of serine hydrolyses that cleaves the palmitoleate moiety from Wingless-related integration site (Wnt) ligands. This enzyme plays crucial functions through modulating the Wnt signaling pathway. Inhibition of Notum carries therapeutic effects against a number of maladies including osteoporosis, cancer, and Alzheimer's disease. Recently, a class of irreversible inhibitors based on esters of 4-(indolin-1-yl)-4-oxobutanoic acid have been reported. Using the crystal structures of enzyme-4-(indolin-1-yl)-4-oxobutanoate adduct and 4-(indolin-1-yl)-4-oxobutanoic acid-enzyme complex, we studied computationally the proposed inhibition mechanism using model systems based on the own n-layered integrated molecular orbital and molecular mechanics (ONIOM) method. In the first place, model systems were formulated to investigate the transesterification between the catalytic serine residue, Ser-232, and the methyl ester of 4-(indolin-1-yl)-4-oxobutanoate. In the second place, the hydrolysis mechanism of the resultant enzyme-inhibitor adduct was studied. The energetics of these steps were analyzed using a density functional theory functional in the ONIOM method. In addition, the roles of active-site residues during these steps were highlighted. It was found that the hydrolysis of the covalent adduct is highly endergonic corroborating the irreversible inhibition mechanism. These results will shed light not only on the inhibition mechanism but also on the catalytic mechanism.

Identifiants

pubmed: 35474786
doi: 10.1021/acsomega.2c01044
pmc: PMC9026088
doi:

Types de publication

Journal Article

Langues

eng

Pagination

13333-13342

Informations de copyright

© 2022 The Authors. Published by American Chemical Society.

Déclaration de conflit d'intérêts

The authors declare no competing financial interest.

Références

J Med Chem. 2020 Nov 12;63(21):12942-12956
pubmed: 33124429
J Mol Graph. 1996 Feb;14(1):33-8, 27-8
pubmed: 8744570
J Am Chem Soc. 2002 Sep 4;124(35):10572-7
pubmed: 12197759
J Mol Graph Model. 2014 Nov;54:131-40
pubmed: 25459765
J Med Chem. 2021 Aug 12;64(15):11354-11363
pubmed: 34292747
BMC Biochem. 2006 Jun 02;7:18
pubmed: 16749919
Cell Rep. 2020 Jun 23;31(12):107805
pubmed: 32579931
Nature. 2015 Mar 12;519(7542):187-192
pubmed: 25731175
Nature. 2021 Jun;594(7863):430-435
pubmed: 34079124
Dev Cell. 2015 Mar 23;32(6):719-30
pubmed: 25771893
J Biol Chem. 2010 Apr 9;285(15):11051-5
pubmed: 20147750
J Am Chem Soc. 2009 Aug 26;131(33):11964-75
pubmed: 19642701
ACS Med Chem Lett. 2018 May 26;9(6):563-568
pubmed: 29937983
Biochemistry. 2014 Sep 16;53(36):5820-9
pubmed: 25101647
Bioorg Med Chem Lett. 2016 Mar 15;26(6):1525-1528
pubmed: 26897593
Bone Res. 2019 Jan 8;7:2
pubmed: 30622831
Bioorg Med Chem Lett. 2016 Feb 15;26(4):1184-7
pubmed: 26821819
Brain Sci. 2020 Nov 24;10(12):
pubmed: 33255414
Cell Metab. 2018 May 01;27(5):1138-1155.e6
pubmed: 29719227
Chem Rev. 2011 Oct 12;111(10):6022-63
pubmed: 21696217
Proteins. 2006 Nov 15;65(3):712-25
pubmed: 16981200
J Chem Theory Comput. 2006 May;2(3):815-26
pubmed: 26626688
Acta Pharm Sin B. 2018 Sep;8(5):699-712
pubmed: 30245959

Auteurs

Ibrahim Yildiz (I)

Chemistry Department, Khalifa University, PO Box 127788, Abu Dhabi 00000, UAE.

Banu Sizirici Yildiz (BS)

CIVE Department, Khalifa University, PO Box 127788, Abu Dhabi 00000, UAE.

Classifications MeSH